Capstone Investment Advisors
INFI

Capstone Investment Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Capstone Investment Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-12,709
Closed -$41K – 1951
2021
Q1 		$41K Sell
12,709
-34,326
-73% -$115K ﹤0.01% 1613
2020
Q4 		$100K Buy
+47,035
New +$77.6K ﹤0.01% 1557

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GPC
Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

Capstone Investment Advisors's INFI Position: Q2 2021 in Review

Capstone Investment Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2021, closing a stake of 12,709 shares — an estimated $41K sold.

Capstone Investment Advisors first reported a position in INFI in Q4 2020 and held it in 2 quarters. The position peaked at $100K in Q4 2020. 97 funds tracked by Wall St. Rank hold INFI as of Q2 2021.

  • Capstone Investment Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Capstone Investment Advisors sold 12,709 Infinity Pharmaceuticals, Inc. shares in Q2 2021, an estimated $41K.
  • Capstone Investment Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2020 and held it in 2 quarters.
  • Capstone Investment Advisors's Infinity Pharmaceuticals, Inc. position peaked at $100K in Q4 2020.
  • 97 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2021.

Based on Capstone Investment Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.